Skip to main content
Clinical Trials/ACTRN12621001405808
ACTRN12621001405808
Recruiting
未知

Biomarkers predictive of embryo quality and clinical pregnancy in women prior to undergoing antagonist treatment assisted reproductive therapy

Drop Bio Pty Ltd0 sites400 target enrollmentOctober 18, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Assisted reproduction
Sponsor
Drop Bio Pty Ltd
Enrollment
400
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2021
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Drop Bio Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Seeking and undergoing fertility treatment at one of Virtus Health’s three major Sydney clinics (Alexandria, Greenwich and Westmead)
  • 3\. 18 \- 42 years of age
  • 4\. Antagonist treatment protocol
  • 5\. Autologous oocyte
  • 6\. In vitro fertilisation (IVF)
  • 7\. Intracytoplasmic sperm injection (ICSI)
  • 8\. Scheduled for a blood collection within the first 72h of menses

Exclusion Criteria

  • 1\. Male\-factor infertility defined by Australia and New Zealand Assisted Reproduction Database (ANZARD) in patient history
  • 2\. Undertaking assisted reproductive therapy (ART) and oocyte or embryo freeze all for fertility preservation
  • 3\. Body Mass Index greater than 35kg.m2 or less than 18\.5kg.m2
  • 4\. Currently receiving steroid based therapy in the last two weeks
  • 5\. Recent antimicrobial treatment n the last two weeks
  • 6\. Recent iron infusion OR infusion/transfusion based therapy n the last 12 weeks
  • 7\. Genetic disorder(s) diagnosis
  • 8\. Any past history of chemotherapy
  • 9\. Autoimmune disorder(s) diagnosis
  • 10\. Recent surgery within n the last 12 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials